KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Clorox (CLX) Research & Development (2016 - 2025)

Clorox (CLX) has 16 years of Research & Development data on record, last reported at $29.0 million in Q4 2025.

  • For Q4 2025, Research & Development fell 6.45% year-over-year to $29.0 million; the TTM value through Dec 2025 reached $116.0 million, down 8.66%, while the annual FY2025 figure was $121.0 million, 3.97% down from the prior year.
  • Research & Development reached $29.0 million in Q4 2025 per CLX's latest filing, up from $28.0 million in the prior quarter.
  • Across five years, Research & Development topped out at $45.0 million in Q2 2021 and bottomed at $27.0 million in Q1 2025.
  • Average Research & Development over 5 years is $32.6 million, with a median of $32.0 million recorded in 2021.
  • Peak YoY movement for Research & Development: decreased 24.44% in 2022, then rose 12.9% in 2023.
  • A 5-year view of Research & Development shows it stood at $34.0 million in 2021, then dropped by 2.94% to $33.0 million in 2022, then dropped by 3.03% to $32.0 million in 2023, then dropped by 3.12% to $31.0 million in 2024, then decreased by 6.45% to $29.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Research & Development were $29.0 million in Q4 2025, $28.0 million in Q3 2025, and $32.0 million in Q2 2025.